Ew Healthcare Partners Fund 2, L.P.'s Form 4 filing
TELA Bio, Inc. (TELA) · filed Aug 19, 2022
- Accession no.
- 0000899243-22-029273
- Filed
- Aug 19, 2022, 4:07 PM ET
- Trade date
- Aug 17, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $4.00M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ew Healthcare Partners Fund 2, L.P.CIK 0001746777 | Other: See footnote 2 |
| Ew Healthcare Partners Fund 2-A, L.P.CIK 0001746779 | 10% Owner, Other: See footnote 2 |
| EW Healthcare Partners Fund 2 GP, L.P.CIK 0001793943 | 10% Owner |
| EW Healthcare Partners Fund 2-UGP, LLCCIK 0001793948 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +500,000 | $8.00 | +$4,000,000 | 4,105,709 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.